NEXTERA MEDICAL Trademark
Trademark Overview
On Tuesday, January 20, 1998, a trademark application was filed for NEXTERA MEDICAL with the United States Patent and Trademark Office. The USPTO has given the NEXTERA MEDICAL trademark a serial number of 75420074. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Friday, July 28, 2000. This trademark is owned by NextEra Medical, LLC. The NEXTERA MEDICAL trademark is filed in the Pharmaceutical Products category with the following description:
Injectable, intravenous or topical pharmaceutical preparations for; the treatment of cancers, viral and bacterial infections, disorders involving damaged tissue, namely, vascular disorders, trauma, rheumatic diseases, wounds and burns; enhancing natural immune responses; diagnosing sites in body where tissues are compromised and disease is present; use in combination with alternative therapies such as chemotherapeutic drugs, antimicrobial drugs and biological response modifier proteins for the purpose of enhancing the therapeutic effects of such alternative therapies and to moderate or mitigate the toxicity associated with such alternative therapies
General Information
| Serial Number | 75420074 |
| Word Mark | NEXTERA MEDICAL |
| Filing Date | Tuesday, January 20, 1998 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Friday, July 28, 2000 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, May 4, 1999 |
Trademark Statements
| Disclaimer with Predetermined Text | "MEDICAL" |
| Goods and Services | Injectable, intravenous or topical pharmaceutical preparations for; the treatment of cancers, viral and bacterial infections, disorders involving damaged tissue, namely, vascular disorders, trauma, rheumatic diseases, wounds and burns; enhancing natural immune responses; diagnosing sites in body where tissues are compromised and disease is present; use in combination with alternative therapies such as chemotherapeutic drugs, antimicrobial drugs and biological response modifier proteins for the purpose of enhancing the therapeutic effects of such alternative therapies and to moderate or mitigate the toxicity associated with such alternative therapies |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 6, 1998 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | NextEra Medical, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Columbus, OH 43221 |
| Party Name | NextEra Medical, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Columbus, OH 43221 |
Trademark Events
| Event Date | Event Description |
| Friday, March 16, 2001 | ABANDONMENT - NO USE STATEMENT FILED |
| Friday, February 4, 2000 | EXTENSION 1 GRANTED |
| Monday, December 13, 1999 | EXTENSION 1 FILED |
| Tuesday, July 27, 1999 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, May 4, 1999 | PUBLISHED FOR OPPOSITION |
| Friday, April 2, 1999 | NOTICE OF PUBLICATION |
| Wednesday, January 27, 1999 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, December 10, 1998 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, June 10, 1998 | NON-FINAL ACTION MAILED |
| Tuesday, June 9, 1998 | ASSIGNED TO EXAMINER |
